N-terminal modification raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-28. Anything still debated is marked as such rather than presented as settled.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
1993/2046) Police (Amendment) (No.3) Regulations 1993 (S.I. 1993/2047) Goods Vehicles (Plating and Testing) (Amendment) Regulations 1993 (S.I. 1993/2048) National Health Service (Travelling Expenses and Remission of Charges) (Scotland) Amendment (No.2) Regulations 1993 (S.I. 1993/2049) Prisoners and Criminal Proceedings (Scotland) Act 1993 Commencement, Transitional Provisions and Savings Order 1993 (S.I. 1993/2050) A34 Trunk Road (A34/M4 Junction 13 Improvement) Line and Slip Roads Order 1993 (S.I. 1993/2056) A6 Trunk Road (Great Glen Bypass) Order 1993 (S.I. 1993/2057) A6 Trunk Road (Great Glen Bypass) (Detrunking) Order 1993 (S.I. 1993/2058) Easington Lagoons (Area of Special Protection) (No.2) Order 1993 (S.I. 1993/2059) Capacity Serving Measures (Intoxicating Liquor) (Amendment) Regulations 1993 (S.I. 1993/2060) Enforcement of Road Traffic Debts (Certificated Bailiffs) Regulations 1993 (S.I. 1993/2072) Enforcement of Road Traffic Debts Order 1993 (S.I. 1993/2073) Education (School Performance Information) (England) (No. 2) Regulations 1993 (S.I. 1993/2077) Housing Renovation etc. Grants (Prescribed Forms and Particulars) (Welsh Forms and Particulars) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/2078) Lerwick Harbour Revision Order 1993 (S.I. 1993/2087) Safety of Sports Grounds (Designation) Order 1993 (S.I. 1993/2090) Essex and Greater London (County Boundaries) Order 1993 (S.I. 1993/2091) Social Security (Contributions) Amendment (No. 6) Regulations 1993 (S.I. 1993/2094) Local Authorities (Goods and Services) (Public Bodies) Order 1993 (S.I.
== Research == In 2018, the World Health Organization listed snakebite envenoming as a neglected tropical disease. In 2019, they launched a strategy to prevent and control snakebite envenoming, which involved a program targeting affected communities and their health systems. A policy analysis however found that the placement of snakebite in the global health agenda of WHO is fragile due to reluctance to accept the disease in the neglected tropical disease community and the perceived colonial nature of the network driving the agenda. Key institutions conducting snakebite research on snakebite are the George Institute for Global Health, the Liverpool School of Tropical Medicine, and the Indian Institute of Science.
On February 26, 2025, Trump posted an AI-generated video on social media. The clip depicts the Gaza Strip transformed into a luxury resort called "Trump Gaza" and features Trump and Israeli prime minister Benjamin Netanyahu sunbathing, children emerging from rubble into an upscale setting, a golden statue of Trump, scenes of bearded men dancing in bikinis, Trump standing with a belly dancer, and a figure resembling Elon Musk being showered with banknotes. The video received criticism from Arabs and Muslims in the US and abroad, as well as from Republicans and conservatives on Truth Social and Instagram. It was not created by Trump; NBC News reported that it was first posted on social media on February 7 by a pro-Israel X account. The creators of the video, Solo Avital and Ariel Vromen, later came out saying they did not know how Trump obtained it and criticized him for posting it without credit or permission. They described it as being created as satire and as a joke, rather than a political statement, and said they did not support Trump's "propaganda machine". The Economist suggested the video typifies a new form of political communication, where "knowingly absurd" AI-generated content conveys controversial ideas under the plausible deniability of humor.
Sources: en.wikipedia.org
Gamma irradiation is widely used due to its high penetration depth and dose uniformity, allowing for large-scale applications with high throughput. Additionally, gamma irradiation is significantly less expensive than using an X-ray source. In most designs, the radioisotope, contained in stainless steel pencils, is stored in a water-filled storage pool which absorbs the radiation energy when not in use. For treatment, the source is lifted out of the storage tank, and product contained in totes is passed around the pencils to achieve required processing. Treatment costs vary as a function of dose and facility usage. A pallet or tote is typically exposed for several minutes to hours depending on dose. Low-dose applications such as disinfestation of fruit range between US$0.01/lb and US$0.08/lb while higher-dose applications can cost as much as US$0.20/lb.
These adverse effects were reversed when the regimen stopped, but it was fatal in some patients with protracted vomiting. Milk-alkali syndrome declined in men after effective treatments for peptic ulcer disease arose. Since the 1990s it has been most frequently reported in women taking calcium supplements above the recommended range of 1.2 to 1.5 grams daily, for prevention and treatment of osteoporosis, and is exacerbated by dehydration. Calcium has been added to over-the-counter products, which contributes to inadvertent excessive intake. Excessive calcium intake can lead to hypercalcemia, complications of which include vomiting, abdominal pain and altered mental status. As a food additive it is designated E170, and it has an INS number of 170. Used as an acidity regulator, anticaking agent, stabilizer or color it is approved for usage in the EU, US and Australia and New Zealand. It is "added by law to all UK milled bread flour except wholemeal". It is used in some soy milk and almond milk products as a source of dietary calcium; at least one study suggests that calcium carbonate might be as bioavailable as the calcium in cow's milk. Calcium carbonate is also used as a firming agent in many canned and bottled vegetable products. Several calcium supplement formulations have been documented to contain the chemical element lead, posing a public health concern. Lead is commonly found in natural sources of calcium.
== Medical use == Clinical laboratories can use this growth medium to diagnose and further speciate fungal infections, allowing medical professionals to provide appropriate treatment with antifungal medications. Histoplasma and other fungal causes of atypical pneumonia can be grown on this medium. Sabouraud agar used in combination with additional media, such as Inhibitory Mold Agar (IMA), improves identification of fungal clinical isolates.
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.